Atika Capital Management LLC Karuna Therapeutics, Inc. Transaction History

Atika Capital Management LLC

$867 Million
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$161.01 - $317.85 $3.78 Million - $7.47 Million	-23,500 Reduced 54.02%	20,000 $6.33 Million
Q3 2023 Nov 13, 2023	SELL	$164.66 - $218.08 $3.54 Million - $4.69 Million	-21,500 Reduced 33.08%	43,500 $7.36 Million
Q2 2023 Aug 11, 2023	BUY	$176.32 - $240.22 $4.01 Million - $5.46 Million	22,725 Added 53.76%	65,000 $14.1 Million
Q1 2023 May 12, 2023	SELL	$161.33 - $204.36 $1.1 Million - $1.39 Million	-6,806 Reduced 13.87%	42,275 $7.68 Million
Q4 2022 Feb 13, 2023	SELL	$191.53 - $236.82 $8.03 Million - $9.93 Million	-41,919 Reduced 46.06%	49,081 $9.64 Million

Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $4.7 Million - $10.5 Million	38,000 Added 71.7%	91,000 $20.5 Million
Q2 2022 Aug 12, 2022	SELL	$93.97 - $143.33 $1.79 Million - $2.72 Million	-19,000 Reduced 26.39%	53,000 $6.71 Million
Q1 2022 May 13, 2022	SELL	$98.9 - $132.37 $296,700 - $397,110	-3,000 Reduced 4.0%	72,000 $9.13 Million
Q4 2021 Feb 11, 2022	BUY	$110.64 - $159.4 $8.3 Million - $12 Million	75,000 New	75,000 $9.83 Million
Q2 2021 Aug 12, 2021	SELL	$107.45 - $135.95 $1.18 Million - $1.5 Million	-11,000 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$95.46 - $133.08 $5.06 Million - $7.05 Million	-53,000 Reduced 82.81%	11,000 $1.32 Million
Q4 2020 Feb 16, 2021	SELL	$75.23 - $109.23 $714,685 - $1.04 Million	-9,500 Reduced 12.93%	64,000 $6.5 Million
Q3 2020 Nov 13, 2020	SELL	$71.31 - $109.74 $106,965 - $164,610	-1,500 Reduced 2.0%	73,500 $5.68 Million
Q2 2020 Aug 13, 2020	SELL	$62.14 - $117.21 $932,100 - $1.76 Million	-15,000 Reduced 16.67%	75,000 $8.36 Million
Q1 2020 May 14, 2020	BUY	$60.41 - $115.92 $1.03 Million - $1.97 Million	17,000 Added 23.29%	90,000 $6.48 Million
Q4 2019 Feb 14, 2020	BUY	$11.44 - $123.99 $835,120 - $9.05 Million	73,000 New	73,000 $5.5 Million

Others Institutions Holding KRTX

# of Institutions

Shares Held

333K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atika Capital Management LLC with notifications on news.

Account